AI assistant
Sending…
AIM ImmunoTech Inc. — Director's Dealing 2021
Nov 19, 2021
35334_dirs_2021-11-19_3e3bc151-d2ae-4746-892c-1d0563301f6a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2021-11-19
Reporting Person: EQUELS THOMAS K. (Director, CEO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-19 | Common Stock | A | 10204 | $1.47 | Acquired | 244605 | Direct |
More from AIM ImmunoTech Inc.
Capital/Financing Update
2026
Jun 8
Report Publication Announcement
2026
Jun 4
Capital/Financing Update
2026
May 21
Capital/Financing Update
2026
May 21
Share Issue/Capital Change
2026
May 19
Capital/Financing Update
2026
May 19
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14
Capital/Financing Update
2026
May 12
Capital/Financing Update
2026
May 8